# Lilly bets $7 billion that the future of cancer cell therapy needs no factory - Date: 2026-04-20 - Category: Biotech & Life Sciences Lilly just paid up to $7 billion for a company that reprogrammes cancer-fighting immune cells inside the patient instead of in a factory. All four Phase 1 patients showed no detectable cancer cells, none needed severe immune reactions, and the Series A was $50 million. ---